Instruments and reagents for blood analysis

Boule Diagnostics

Boule Diagnostics is a Swedish diagnostics company that develops, manufactures and markets instruments and consumable products for blood diagnostics, specializing in blood cell counting (CBC) systems, in both human and veterinary hematology. Boule Diagnostics is a global company with approximately 170 employees located in Sweden, USA and Mexico and with a market presence via distributors in addition to its own sales and marketing organisation in more than 100 countries.

Financials

BOULE DIAGNOSTICS

SEKm 2018 2019 2020
Sales 434 480 525
Sales growth (%) 1,5 10,7 9,3
EBITDA 76 89 N/A
EBITDA margin (%) 15,3 17,5 18,6
EBIT adj 54 67 79
EBIT adj margin (%) 12,7 15,4 16,4
Pretax profit 67 78 86
EPS rep 2,59 3 3,31
EPS growth (%) 33,1 16,1 10,4
EPS adj 2,59 3 3,31
DPS 1 1 1,25
EV/EBITDA (x) 12,6 10,5 9,1
EV/EBIT adj (x) 14,2 11,9 10,4
P/E (x) 20,7 17,8 16,1
P/E adj (x) 20,7 17,8 16,1
EV/sales (x) 2,2 2 1,7
FCF yield (%) -1,8 3,2 4,6
Dividend yield (%) 1,9 1,9 2,3
Net IB debt/EBITDA -1,5 -1,4 -1,5

Main shareholders

Boule Diagnostics

Main shareholders Share capital % Voting shares % Verified
Martin Gren (Grenspecialisten) 10.7 % 10.7 % 31 Dec 2018
Svolder 10.0 % 10.0 % 31 Dec 2018
SEB Fonder 7.8 % 9.8 % 31 Dec 2018
Thomas Eklund 9.3 % 9.3 % 31 Dec 2018
Swedbank Robur Fonder 9.2 % 9.2 % 31 Dec 2018
Tredje AP-fonden 6.2 % 6.2 % 31 Dec 2018
Handelsbanken Fonder 5.9 % 5.9 % 31 Dec 2018
Länsförsäkringar Fonder 4.4 % 4.4 % 31 Dec 2018
Berenberg Funds 3.4 % 3.4 % 31 Oct 2018
Norges Bank 2.8 % 2.8 % 31 Dec 2018
Source: Holdings by Modular Finance AB

Insider list

Boule Diagnostics

Name
Gustaf Peter Reinhold von Ehrenheim
Claes Blanche
Claes Blanche
Fredrik Ekdahl
Christina Rubenhag
Christina Rubenhag
Hans Johansson
Claes Blanche
Fredrik Dalborg
Fredrik Alpsten
Show More